PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Best Practice & Research Clinical Haematology10.1016/j.beha.2008.07.0072008213559-577Cellular immunotherapy for multiple myelomaJacalyn Rosenblatt, David Aviganhttps://api.elsevier.com/content/article/PII:S1521692608000637?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1521692608000637?httpAccept=text/plain
Pharmaceuticals10.3390/ph90100032016913The Role of Immunotherapy in Multiple MyelomaMehmet Kocoglu, Ashraf Badroshttp://www.mdpi.com/1424-8247/9/1/3/pdf
Molecular Therapy10.1016/s1525-0016(16)34961-9201321S239626. T-Cell Immunotherapy for Multiple Myelomahttps://api.elsevier.com/content/article/PII:S1525001616349619?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525001616349619?httpAccept=text/plain
Clinical Lymphoma Myeloma and Leukemia10.1016/j.clml.2015.08.064201515e33CAR-T Cellular Therapies for Multiple MyelomaE.A. Stadtmauerhttps://api.elsevier.com/content/article/PII:S2152265015011623?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2152265015011623?httpAccept=text/plain
Clinical Lymphoma Myeloma and Leukemia10.1016/j.clml.2015.08.094201515e319Cellular Immunotherapy for Myeloma using Chimeric Antigen Receptor Modified T Cells (CARs)P. Manganhttps://api.elsevier.com/content/article/PII:S2152265015012720?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2152265015012720?httpAccept=text/plain
Clinical Lymphoma Myeloma and Leukemia10.1016/j.clml.2013.05.021201313S330-S348Allogeneic Stem Cell Transplantation and Targeted Immunotherapy for Multiple MyelomaIvetta Danylesko, Avichai Shimoni, Arnon Naglerhttps://api.elsevier.com/content/article/PII:S2152265013002383?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2152265013002383?httpAccept=text/plain
Clinical Lymphoma Myeloma and Leukemia10.1016/j.clml.2019.09.27120191910e162-e163Immunotherapy in Multiple Myeloma: Boom or Bust? Investigating Oligoclonal Banding and Survival in Multiple Myeloma Patients Receiving Anti CD3-CD28 Co-Stimulated and Engineered Autologous T cells after Autologous Stem Cell Transplant.Dina Ioffe, Olga Goloubeva, Aaron Rapoporthttps://api.elsevier.com/content/article/PII:S2152265019316581?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2152265019316581?httpAccept=text/plain
Cancer10.1002/cncr.312432018124102075-2085Current developments in immunotherapy in the treatment of multiple myelomaMartin Köhler, Christine Greil, Michael Hudecek, Sagar Lonial, Noopur Raje, Ralph Wäsch, Monika Engelhardthttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fcncr.31243, https://onlinelibrary.wiley.com/doi/full/10.1002/cncr.31243
Journal of Cellular Immunotherapy10.1016/j.jocit.2014.11.00120162128-35CD138-directed adoptive immunotherapy of chimeric antigen receptor (CAR)-modified T cells for multiple myelomaBo Guo, Meixia Chen, Qingwang Han, Fan Hui, Hanren Dai, Wenying Zhang, Yajing Zhang, Yao Wang, Hongli Zhu, Weidong Hanhttps://api.elsevier.com/content/article/PII:S2352177515000023?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S2352177515000023?httpAccept=text/plain
Clinical Lymphoma Myeloma and Leukemia10.1016/j.clml.2014.04.015201414S6-S13Humoral and Cellular Immunotherapy in ALL in Children, Adolescents, and Young AdultsJessica Hochberg, Nader Kim El-Mallawany, Mitchell S. Cairohttps://api.elsevier.com/content/article/PII:S215226501400161X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S215226501400161X?httpAccept=text/plain